Copyright
©The Author(s) 2023.
World J Exp Med. Jun 20, 2023; 13(3): 17-27
Published online Jun 20, 2023. doi: 10.5493/wjem.v13.i3.17
Published online Jun 20, 2023. doi: 10.5493/wjem.v13.i3.17
Table 1 Cancer distribution by affected organs and gender
All, n = 6106 | Females, n = 4169 (68.3%) | Males, n = 1937 (31.7%) | |
Breast | 1631 (26.7) | 1560 (37.4) | 71 (3.7) |
Cervix | 1138 (18.6) | 1138 (27.3) | - |
Prostate | 678 (11.1) | - | 678 (35) |
Skin | 356 (5.8) | 186 (4.5) | 170 (8.8) |
Blood and LO | 206 (3.4) | 95 (2.3) | 111 (5.7) |
Uterus | 196 (3.2) | 196 (4.7) | - |
Colon | 173 (2.8) | 92 (2.2) | 81 (4.2) |
Lungs | 161 (2.6) | 60 (1.4) | 101 (5.2) |
Stomach | 112 (1.8) | 45 (1.1) | 67 (3.5) |
Bone | 110 (1.8) | 58 (1.4) | 52 (2.7) |
Thyroid | 106 (1.7) | 84 (2) | 22 (1.1) |
Anus/rectum | 97 (1.6) | 51 (1.2) | 46 (2.4) |
KS | 87 (1.4) | 22 (0.5) | 65 (3.4) |
Soft tissue | 87 (1.4) | 52 (1.2) | 35 (1.8) |
Eye | 77 (1.3) | 35 (0.8) | 42 (2.2) |
Ovary | 77 (1.3) | 77 (1.8) | - |
Mouth | 76 (1.2) | 44 (1.1) | 32 (1.7) |
Vagina | 75 (1.2) | 75 (1.8) | - |
Urinary bladder | 73 (1.2) | 32 (0.8) | 41 (2.1) |
Larynx | 65 (1.1) | 11 (0.3) | 54 (2.8) |
Nose | 62 (1.0) | 28 (0.7) | 34 (1.8) |
Peritoneum | 51 (0.8) | 24 (0.6) | 27 (1.4) |
Liver | 49 (0.8) | 24 (0.6) | 25 (1.3) |
Kidneys | 41 (0.7) | 21 (0.5) | 20 (1) |
Vulva | 41 (0.7) | 41 (1) | - |
Ureter | 33 (0.5) | 14 (0.3) | 19 (1) |
Pharynx/nasopharynx | 33 (0.5) | 19 (0.4) | 14 (0.7) |
Intestines | 29 (0.5) | 16 (0.4) | 13 (0.7) |
Pancreas | 29 (0.5) | 13 (0.3) | 16 (0.8) |
Greater omentum | 22 (0.4) | 15 (0.4) | 7 (0.4) |
Esophagus | 21 (0.3) | 8 (0.2) | 13 (0.7) |
Penis | 20 (0.3) | - | 20 (1) |
Testicles | 20 (0.3) | - | 20 (1) |
Tonsils | 13 (0.2) | 5 (0.1) | 8 (0.4) |
Brain | 10 (0.2) | 6 (0.1) | 4 (0.2) |
Coecum | 10 (0.2) | 4 (0.1) | 6 (0.3) |
Vocal cords | 8 (0.1) | 1 (0.0) | 7 (0.4) |
Ears | 7 (0.1) | 5 (0.1) | 2 (0.1) |
Parotid glands | 7 (0.1) | 2 (0.0) | 5 (0.3) |
Duodenum | 6 (0.1) | 2 (0.0) | 4 (0.2) |
Palate | 4 (0.1) | 4 (0.1) | 0 (0.0) |
Forehead | 2 (0.0) | 1 (0.0) | 1 (0.1) |
Glottis | 2 (0.0) | 0 (0.0) | 2 (0.1) |
Trachea | 2 (0.0) | 1 (0.0) | 1 (0.1) |
Sweat glands | 1 (0.0) | 1 (0.0) | 0 (0.0) |
Maxillary | 1 (0.0) | 1 (0.0) | 0 (0.0) |
Spleen | 1 (0.0) | 0 (0.0) | 1 (0.1) |
Table 2 Cancer distribution by age group
Cancers | ≤ 40 yr, n (1409) | % | 41-60 yr, n (2689) | % | ≥ 61 yr, n (2008) | % |
Prostate | 25 | 1.8 | 122 | 4.5 | 531 | 26.4 |
Cervical | 156 | 11.1 | 611 | 22.7 | 371 | 18.5 |
Breast | 403 | 28.6 | 895 | 33.3 | 333 | 16.6 |
Skin | 141 | 10.0 | 133 | 4.9 | 82 | 4 |
Uterus | 22 | 1.6 | 107 | 4.0 | 67 | 3.3 |
Lungs | 30 | 2.1 | 64 | 2.4 | 67 | 3.3 |
Blood and LO | 106 | 7.5 | 48 | 1.8 | 52 | 2.6 |
Colon | 37 | 2.6 | 92 | 3.4 | 44 | 2.2 |
Stomach | 19 | 1.3 | 60 | 2.2 | 33 | 1.6 |
KS | 32 | 2.3 | 24 | 0.9 | 31 | 1.5 |
Soft tissue | 27 | 1.9 | 30 | 1.1 | 30 | 1.5 |
Vessels | 13 | 0.9 | 32 | 1.2 | 28 | 1.4 |
Bones | 51 | 3.6 | 33 | 1.2 | 26 | 1.3 |
Vagina | 16 | 1.1 | 33 | 1.2 | 26 | 1.3 |
Larynx | 18 | 1.3 | 21 | 0.8 | 26 | 1.3 |
Anus-rectum | 27 | 1.9 | 45 | 1.7 | 25 | 1.2 |
Thyroid | 37 | 2.6 | 45 | 1.7 | 24 | 1.2 |
Mouth | 28 | 2.0 | 24 | 0.9 | 24 | 1.2 |
Liver | 12 | 0.9 | 19 | 0.7 | 18 | 0.9 |
Ureter | 3 | 0.2 | 12 | 0.4 | 18 | 0.9 |
Vulva | 4 | 0.3 | 20 | 0.7 | 17 | 0.8 |
Ovary | 25 | 1.8 | 36 | 1.3 | 16 | 0.8 |
Peritoneum | 12 | 0.9 | 23 | 0.9 | 16 | 0.8 |
Nose | 26 | 1.8 | 23 | 0.9 | 13 | 0.6 |
Eye | 35 | 2.5 | 30 | 1.1 | 12 | 0.6 |
Esophagus | 5 | 0.4 | 6 | 0.2 | 10 | 0.5 |
Testicles | 8 | 0.6 | 2 | 0.1 | 10 | 0.5 |
Pharynx | 14 | 1.0 | 8 | 0.3 | 9 | 0.4 |
Pancreas | 5 | 0.4 | 16 | 0.6 | 8 | 0.4 |
Intestines | 7 | 0.5 | 15 | 0.6 | 7 | 0.3 |
Kidney | 23 | 1.6 | 11 | 0.4 | 7 | 0.3 |
Vocal cords | 1 | 0.1 | 2 | 0.1 | 5 | 0.2 |
Greater omentum | 7 | 0.5 | 11 | 0.4 | 4 | 0.2 |
Penis | 5 | 0.4 | 12 | 0.4 | 3 | 0.1 |
Duodenum | 1 | 0.1 | 2 | 0.1 | 3 | 0.1 |
Tonsils | 4 | 0.3 | 7 | 0.3 | 2 | 0.1 |
Coecum | 5 | 0.4 | 3 | 0.1 | 2 | 0.1 |
Ears | 4 | 0.3 | 1 | 0.0 | 2 | 0.1 |
Palate | 1 | 0.1 | 1 | 0.0 | 2 | 0.1 |
Parotid glands | 3 | 0.2 | 3 | 0.1 | 1 | 0.0 |
Trachea | 1 | 0.1 | 0 | 0.0 | 1 | 0.0 |
Maxillary | 0 | 0.0 | 0 | 0.0 | 1 | 0.0 |
Spleen | 0 | 0.0 | 0 | 0.0 | 1 | 0.0 |
Brain | 6 | 0.4 | 4 | 0.1 | 0 | 0.0 |
Glottis | 0 | 0.0 | 2 | 0.1 | 0 | 0.0 |
Nasopharynx | 1 | 0.1 | 1 | 0.0 | 0 | 0.0 |
Forehead | 2 | 0.1 | 0 | 0.0 | 0 | 0.0 |
Sweat glands | 1 | 0.1 | 0 | 0.0 | 0 | 0.0 |
Table 3 Frequency and distribution of the cases of thyroid cancer according to histological type
Variables | Number of cases | Percentage (%) |
Histology | ||
Papillary carcinoma | 71 | 67.0 |
Follicular carcinoma | 23 | 21.7 |
Anaplastic carcinoma | 8 | 7.5 |
Lymphoma | 3 | 2.8 |
Medullary carcinoma | 1 | 0.9 |
- Citation: Bukasa-Kakamba J, Bangolo AI, Bayauli P, Mbunga B, Iyese F, Nkodila A, Atoot A, Anand G, Lee SH, Chaudhary M, Fernandes PQ, Mannam HP, Polavarapu A, Merajunnissa M, Azhar A, Alichetty MN, Singh G, Arana Jr GV, Sekhon I, Singh M, Rodriguez-Castro JD, Atoot A, Weissman S, M’buyamba JR. Proportion of thyroid cancer and other cancers in the democratic republic of Congo. World J Exp Med 2023; 13(3): 17-27
- URL: https://www.wjgnet.com/2220-315x/full/v13/i3/17.htm
- DOI: https://dx.doi.org/10.5493/wjem.v13.i3.17